S. Tries
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Pharmacological Effects of Natural Compounds
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Plant Toxicity and Pharmacological Properties 4
- Cancer therapeutics and mechanisms 2
-
- Pharmacological Effects of Natural Compounds 5
- Inflammatory mediators and NSAID effects 3
- Co-authors
- Stefan Laufer (14 shared papers)Dragan Jovanović (1 shared paper)Johanne Martel-Pelletier (1 shared paper)Julio Fernandes (1 shared paper)Pascal Reboul (1 shared paper)W. McKnight (1 shared paper)John L. Wallace (1 shared paper)William M. Abraham (1 shared paper)
- Journals
- Inflammation Research (3 papers)Inflammopharmacology (1 paper)Pulmonary Pharmacology & Therapeutics (1 paper)European Journal of Pharmacology (1 paper)Archiv der Pharmazie (1 paper)
- Partner nations
- GermanyCanadaUnited States
In The Last Decade
S. Tries
16 papers receiving 437 citations
Peers
Comparison fields: 5 of 58
- Pharmacology 255
- Pharmacology 95
- Biochemistry 69
- Rheumatology 73
- Toxicology 17
Countries citing papers authored by S. Tries
This map shows the geographic impact of S. Tries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Tries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Tries more than expected).
Fields of papers citing papers by S. Tries
This network shows the impact of papers produced by S. Tries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Tries. The network helps show where S. Tries may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Tries, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 85 | |
| 2 | 2002 | 82 | |
| 3 | 2001 | 60 | |
| 4 | 1994 | 38 | |
| 5 | Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors. | 2002 | 30 |
| 6 | Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis. | 2001 | 30 |
| 7 | Acute and chronic anti-inflammatory properties of [2,2-dimethyl-6-(4- chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid. | 1995 | 25 |
| 8 | 1997 | 24 | |
| 9 | 1997 | 19 | |
| 10 | Gastrointestinal tolerance of [2,2-dimethyl-6-(4-chlorophenyl-7-phenyl- 2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid in the rat. | 1994 | 17 |
| 11 | General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals. | 1995 | 16 |
| 12 | 2002 | 14 | |
| 13 | Studies on the in vitro and in vivo genotoxicity of [2,2-dimethyl-6- (4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid. | 1995 | 5 |
| 14 | 2001 | 4 | |
| 15 | 1991 | 2 | |
| 16 | 1998 | 1 |
About S. Tries
S. Tries is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Pharmacology and Surgery, having authored 16 papers that have together received 452 indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (5 papers), Plant Toxicity and Pharmacological Properties (4 papers), Chemical synthesis and pharmacological studies (3 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer therapeutics and mechanisms (2 papers), Synthesis and Biological Evaluation (2 papers), Osteoarthritis Treatment and Mechanisms (1 paper) and Synthesis of β-Lactam Compounds (1 paper). The work is most often cited by research in Pharmacology (255 citations), Pharmacology (95 citations), Biochemistry (69 citations), Rheumatology (73 citations) and Toxicology (17 citations). S. Tries has collaborated with scholars based in Germany, Canada and United States. Frequent co-authors include Stefan Laufer, Dragan Jovanović, Johanne Martel-Pelletier, Julio Fernandes, Pascal Reboul, W. McKnight, John L. Wallace, William M. Abraham, Steffen Gay and R E Gay. Their work appears in journals such as Inflammation Research, Inflammopharmacology, Pulmonary Pharmacology & Therapeutics, European Journal of Pharmacology and Archiv der Pharmazie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.